{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:59:12Z","timestamp":1762523952863,"version":"build-2065373602"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"CAMS Innovation Fund for Medical Sciences","award":["2023-I2M-C&T-B-124"],"award-info":[{"award-number":["2023-I2M-C&T-B-124"]}]},{"name":"Sichuan Science and Technology Program","award":["2023NSFSC0538"],"award-info":[{"award-number":["2023NSFSC0538"]}]},{"name":"Scientific Research Project of Cadre Health Care in Sichuan Province","award":["2023-212"],"award-info":[{"award-number":["2023-212"]}]},{"name":"Medicine-engineering Interdisciplinary Granted by UESTC","award":["ZYGX2021YGLH006"],"award-info":[{"award-number":["ZYGX2021YGLH006"]}]},{"name":"Special Research Project of Research Fund of Sichuan Anti Cancer Association","award":["2022HX040"],"award-info":[{"award-number":["2022HX040"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-07210-x","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:55:25Z","timestamp":1762523725000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The impact of STAiR18 on multiple myeloma survival rates"],"prefix":"10.1186","volume":"23","author":[{"given":"Yingmiao","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haolin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaoya","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yajie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuai","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feifei","family":"Che","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianyou","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3551-9921","authenticated-orcid":false,"given":"Ling","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,7]]},"reference":[{"key":"7210_CR1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41572-024-00529-7","volume":"10","author":"F Malard","year":"2024","unstructured":"Malard F, Neri P, Bahlis NJ, Terpos E, Moukalled N, Hungria VTM, Manier S, Mohty M. Multiple myeloma. Nat Reviews Disease Primers. 2024;10:45.","journal-title":"Nat Reviews Disease Primers"},{"key":"7210_CR2","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/S0140-6736(21)00135-5","volume":"397","author":"NWCJ van de Donk","year":"2021","unstructured":"van de Donk NWCJ, Pawlyn C, Yong KL. Multiple myeloma. Lancet (London England). 2021;397:410\u201327.","journal-title":"Lancet (London England)"},{"key":"7210_CR3","first-page":"178","volume":"36","author":"B Saka","year":"2019","unstructured":"Saka B, Sayito\u011flu M, \u0130stemihan Z, Karan MA, Erten N, Do\u011fan \u00d6, \u00d6zbek U, Gen\u00e7 S, Ta\u015f\u00e7\u0131o\u011flu C, Kalayo\u011flu-Be\u015f\u0131\u015f\u0131k S. The role of the local bone marrow Renin-Angiotensin system in multiple myeloma. Turkish J Haematology: Official J Turkish Soc Haematol. 2019;36:178\u201385.","journal-title":"Turkish J Haematology: Official J Turkish Soc Haematol"},{"key":"7210_CR4","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s10142-018-0631-y","volume":"19","author":"R Zhao","year":"2019","unstructured":"Zhao R, Li FQ, Tian LL, Shang DS, Guo Y, Zhang JR, Liu M. Comprehensive analysis of the whole coding and non-coding RNA transcriptome expression profiles and construction of the circRNA-lncRNA co-regulated CeRNA network in laryngeal squamous cell carcinoma. Funct Integr Genomics. 2019;19:109\u201321.","journal-title":"Funct Integr Genomics"},{"key":"7210_CR5","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.gene.2018.05.046","volume":"671","author":"J Chen","year":"2018","unstructured":"Chen J, Shen Z, Deng H, Zhou W, Liao Q, Mu Y. Long non-coding RNA biomarker for human laryngeal squamous cell carcinoma prognosis. Gene. 2018;671:96\u2013102.","journal-title":"Gene"},{"key":"7210_CR6","doi-asserted-by":"publisher","first-page":"960193","DOI":"10.3389\/fonc.2022.960193","volume":"12","author":"S Li","year":"2022","unstructured":"Li S, Yao W, Liu R, Gao L, Lu Y, Zhang H, Liang X. Long non-coding RNA LINC00152 in cancer: Roles, mechanisms, and chemotherapy and radiotherapy resistance. Front Oncol. 2022;12:960193.","journal-title":"Front Oncol"},{"key":"7210_CR7","doi-asserted-by":"publisher","first-page":"7976","DOI":"10.1038\/s41598-017-08348-5","volume":"7","author":"S Binder","year":"2017","unstructured":"Binder S, H\u00f6sler N, Riedel D, Zipfel I, Buschmann T, K\u00e4mpf C, Reiche K, Burger R, Gramatzki M, Hackerm\u00fcller J, et al. STAT3-induced long noncoding RNAs in multiple myeloma cells display different properties in cancer. Sci Rep. 2017;7:7976.","journal-title":"Sci Rep"},{"key":"7210_CR8","doi-asserted-by":"crossref","unstructured":"Yu Y, Yang J, Li Q, Xu B, Lian Y, Miao L. LINC00152: a pivotal oncogenic long non-coding RNA in human cancers. Cell Prolif. 2017;50.","DOI":"10.1111\/cpr.12349"},{"key":"7210_CR9","doi-asserted-by":"publisher","first-page":"6010721","DOI":"10.1155\/2017\/6010721","volume":"2017","author":"C Miao","year":"2017","unstructured":"Miao C, Zhao K, Zhu J, Liang C, Xu A, Hua Y, Zhang J, Liu S, Tian Y, Zhang C, et al. Clinicopathological and prognostic role of long noncoding RNA Linc00152 in various human neoplasms: evidence from meta-analysis. Biomed Res Int. 2017;2017:6010721.","journal-title":"Biomed Res Int"},{"key":"7210_CR10","doi-asserted-by":"publisher","first-page":"4722","DOI":"10.1002\/cam4.2245","volume":"8","author":"J Xu","year":"2019","unstructured":"Xu J, Guo J, Jiang Y, Liu Y, Liao K, Fu Z, Xiong Z. Improved characterization of the relationship between long intergenic non-coding RNA Linc00152 and the occurrence and development of malignancies. Cancer Med. 2019;8:4722\u201331.","journal-title":"Cancer Med"},{"key":"7210_CR11","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12920-020-0692-3","volume":"13","author":"S Binder","year":"2020","unstructured":"Binder S, Zipfel I, Friedrich M, Riedel D, Ende S, Kampf C, Wiedemann K, Buschmann T, Puppel SH, Reiche K, et al. Master and servant: LINC00152 - a STAT3-induced long noncoding RNA regulates STAT3 in a positive feedback in human multiple myeloma. BMC Med Genomics. 2020;13:22.","journal-title":"BMC Med Genomics"},{"key":"7210_CR12","doi-asserted-by":"crossref","unstructured":"Cai Q, Wang Z, Wang S, Weng M, Zhou D, Li C, Wang J, Chen E, Quan Z. Long non-coding RNA LINC00152 promotes gallbladder cancer metastasis and epithelial-mesenchymal transition by regulating HIF-1\u03b1 via miR-138. Open Biol. 2017;7.","DOI":"10.1098\/rsob.160247"},{"key":"7210_CR13","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.it.2014.12.008","volume":"36","author":"J Mauer","year":"2015","unstructured":"Mauer J, Denson JL, Br\u00fcning JC. Versatile functions for IL-6 in metabolism and cancer. Trends Immunol. 2015;36:92\u2013101.","journal-title":"Trends Immunol"},{"key":"7210_CR14","first-page":"4617","volume":"9","author":"F Cao","year":"2017","unstructured":"Cao F, Zhang Q, Chen W, Han C, He Y, Ran Q, Yao S. IL-6 increases SDCBP expression, cell proliferation, and cell invasion by activating JAK2\/STAT3 in human glioma cells. Am J Transl Res. 2017;9:4617\u201326.","journal-title":"Am J Transl Res"},{"key":"7210_CR15","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1002\/cncr.26297","volume":"118","author":"L Benetatos","year":"2012","unstructured":"Benetatos L, Vartholomatos G. Deregulated MicroRNAs in multiple myeloma. Cancer. 2012;118:878\u201387.","journal-title":"Cancer"},{"key":"7210_CR16","first-page":"1058","volume":"43","author":"F Tian","year":"2019","unstructured":"Tian F, Zhan Y, Zhu W, Li J, Tang M, Chen X, Jiang J. MicroRNA-497 inhibits multiple myeloma growth and increases susceptibility to bortezomib by targeting Bcl-2. Int J Mol Med. 2019;43:1058\u201366.","journal-title":"Int J Mol Med"},{"key":"7210_CR17","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s12032-014-0094-5","volume":"31","author":"J Ma","year":"2014","unstructured":"Ma J, Liu S, Wang Y. MicroRNA-21 and multiple myeloma: small molecule and big function. Med Oncol. 2014;31:94.","journal-title":"Med Oncol"},{"key":"7210_CR18","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1007\/s10565-021-09690-1","volume":"39","author":"F Che","year":"2023","unstructured":"Che F, Ye X, Wang Y, Wang X, Ma S, Tan Y, Mao Y, Luo Z. METTL3 facilitates multiple myeloma tumorigenesis by enhancing YY1 stability and pri-microRNA-27 maturation in m(6)A-dependent manner. Cell Biol Toxicol. 2023;39:2033\u201350.","journal-title":"Cell Biol Toxicol"},{"key":"7210_CR19","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1002\/ijc.28694","volume":"135","author":"CM Gits","year":"2014","unstructured":"Gits CM, van Kuijk PF, Jonkers MB, Boersma AW, Smid M, van Ijcken WF, Coindre JM, Chibon F, Verhoef C, Mathijssen RH, et al. MicroRNA expression profiles distinguish liposarcoma subtypes and implicate miR-145 and miR-451 as tumor suppressors. Int J Cancer. 2014;135:348\u201361.","journal-title":"Int J Cancer"},{"key":"7210_CR20","first-page":"59","volume":"21","author":"LJ Luo Lan","year":"2024","unstructured":"Luo Lan LJ, Wu Yingmiao J, Tao Z, Ling. Study on the clinical application of the Circulating STAiR18 in the monitoring of minimal residual disease in patients with multiple myeloma. Practical J Clin Med. 2024;21:59\u201365. (in Chinese).","journal-title":"Practical J Clin Med"},{"key":"7210_CR21","doi-asserted-by":"publisher","first-page":"101088","DOI":"10.1016\/j.tranon.2021.101088","volume":"14","author":"HY Zhu","year":"2021","unstructured":"Zhu HY, Gao YJ, Wang Y, Liang C, Zhang ZX, Chen Y. LncRNA CRNDE promotes the progression and angiogenesis of pancreatic cancer via miR-451a\/CDKN2D axis. Transl Oncol. 2021;14:101088.","journal-title":"Transl Oncol"},{"key":"7210_CR22","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41419-019-1403-x","volume":"10","author":"K Xu","year":"2019","unstructured":"Xu K, Han B, Bai Y, Ma XY, Ji ZN, Xiong Y, Miao SK, Zhang YY, Zhou LM. miR-451a suppressing BAP31 can inhibit proliferation and increase apoptosis through inducing ER stress in colorectal cancer. Cell Death Dis. 2019;10:152.","journal-title":"Cell Death Dis"},{"key":"7210_CR23","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1007\/s00018-024-05324-x","volume":"81","author":"P Zhai","year":"2024","unstructured":"Zhai P, Tong T, Wang X, Li C, Liu C, Qin X, Li S, Xie F, Mao J, Zhang J, Guo H. Nuclear miR-451a activates KDM7A and leads to cetuximab resistance in head and neck squamous cell carcinoma. Cell Mol Life Sci. 2024;81:282.","journal-title":"Cell Mol Life Sci"},{"key":"7210_CR24","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3892\/ol.2020.12202","volume":"20","author":"L Zhong","year":"2020","unstructured":"Zhong L, Xu Z, Jin X, He Y, Zhang J, Jiang T, Chen J. miR-451a suppression of IL-6R can inhibit proliferation and increase apoptosis through the JAK2\/STAT3 pathway in multiple myeloma. Oncol Lett. 2020;20:339.","journal-title":"Oncol Lett"},{"key":"7210_CR25","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/leu.2017.329","volume":"32","author":"CS Chim","year":"2018","unstructured":"Chim CS, Kumar SK, Orlowski RZ, Cook G, Richardson PG, Gertz MA, Giralt S, Mateos MV, Leleu X, Anderson KC. Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond. Leukemia. 2018;32:252\u201362.","journal-title":"Leukemia"},{"key":"7210_CR26","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/nrclinonc.2014.200","volume":"12","author":"MA Dimopoulos","year":"2015","unstructured":"Dimopoulos MA, Richardson PG, Moreau P, Anderson KC. Current treatment landscape for relapsed and\/or refractory multiple myeloma. Nat Reviews Clin Oncol. 2015;12:42\u201354.","journal-title":"Nat Reviews Clin Oncol"},{"key":"7210_CR27","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13045-022-01272-w","volume":"15","author":"Y Liu","year":"2022","unstructured":"Liu Y, Shi M, He X, Cao Y, Liu P, Li F, Zou S, Wen C, Zhan Q, Xu Z, et al. LncRNA-PACERR induces pro-tumour macrophages via interacting with miR-671-3p and m6A-reader IGF2BP2 in pancreatic ductal adenocarcinoma. J Hematol Oncol. 2022;15:52.","journal-title":"J Hematol Oncol"},{"key":"7210_CR28","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13045-021-01088-0","volume":"14","author":"S-H Kim","year":"2021","unstructured":"Kim S-H, Lim K-H, Yang S, Joo J-Y. Long non-coding RNAs in brain tumors: roles and potential as therapeutic targets. J Hematol Oncol. 2021;14:77.","journal-title":"J Hematol Oncol"},{"key":"7210_CR29","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.semcdb.2023.02.007","volume":"154","author":"X Wang","year":"2024","unstructured":"Wang X, Gu Y, Zhang L, Ma J, Xia Y, Wang X. Long noncoding RNAs regulate intrauterine adhesion and cervical cancer development and progression. Semin Cell Dev Biol. 2024;154:221\u20136.","journal-title":"Semin Cell Dev Biol"},{"key":"7210_CR30","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.gendis.2023.04.006","volume":"11","author":"H Zhao","year":"2024","unstructured":"Zhao H, Yu L, Wang L, Yin X, Liu K, Liu W, Lin S, Wang L. Integrated analysis of single-cell and bulk RNA sequencing data reveals immune-related lncRNA-mRNA prognostic signature in triple-negative breast cancer. Genes Dis. 2024;11:571\u20134.","journal-title":"Genes Dis"},{"key":"7210_CR31","doi-asserted-by":"publisher","first-page":"147910","DOI":"10.1016\/j.gene.2023.147910","volume":"893","author":"J Wu","year":"2024","unstructured":"Wu J, Zhu S, Lin R, Cai W, Lin H, Wu J, Ye L, Wei Y. LINC00887 regulates malignant progression and T-cell chemotaxis in clear cell renal cell carcinoma by activating CD70 via recruitment of SPI1. Gene. 2024;893:147910.","journal-title":"Gene"},{"key":"7210_CR32","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1093\/nar\/gkab065","volume":"49","author":"G Hou","year":"2021","unstructured":"Hou G, Zhao X, Li L, Yang Q, Liu X, Huang C, Lu R, Chen R, Wang Y, Jiang B, Yu J. SUMOylation of YTHDF2 promotes mRNA degradation and cancer progression by increasing its binding affinity with m6A-modified mRNAs. Nucleic Acids Res. 2021;49:2859\u201377.","journal-title":"Nucleic Acids Res"},{"key":"7210_CR33","doi-asserted-by":"publisher","first-page":"188502","DOI":"10.1016\/j.bbcan.2021.188502","volume":"1875","author":"B Goyal","year":"2021","unstructured":"Goyal B, Yadav SRM, Awasthee N, Gupta S, Kunnumakkara AB, Gupta SC. Diagnostic, prognostic, and therapeutic significance of long non-coding RNA MALAT1 in cancer. Biochim Et Biophys Acta Reviews Cancer. 2021;1875:188502.","journal-title":"Biochim Et Biophys Acta Reviews Cancer"},{"key":"7210_CR34","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12935-020-1118-1","volume":"20","author":"X Yang","year":"2020","unstructured":"Yang X, Huang H, Wang X, Liu H, Liu H, Lin Z. Knockdown of LncRNA SNHG16 suppresses multiple myeloma cell proliferation by sponging miR-342-3p. Cancer Cell Int. 2020;20:38.","journal-title":"Cancer Cell Int"},{"key":"7210_CR35","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1158\/1541-7786.MCR-23-0282","volume":"22","author":"Q-M Wang","year":"2024","unstructured":"Wang Q-M, Lian G-Y, Sheng S-M, Xu J, Ye L-L, Min C, Guo S-F. Exosomal LncRNA NEAT1 inhibits NK-Cell activity to promote multiple myeloma cell immune escape via an EZH2\/PBX1 axis. Mol Cancer Research: MCR. 2024;22:125\u201336.","journal-title":"Mol Cancer Research: MCR"},{"key":"7210_CR36","doi-asserted-by":"publisher","first-page":"112971","DOI":"10.1016\/j.biopha.2022.112971","volume":"150","author":"M Zhang","year":"2022","unstructured":"Zhang M, Yu X, Zhang Q, Sun Z, He Y, Guo W. MIR4435-2HG: A newly proposed LncRNA in human cancer. Biomed Pharmacotherapy = Biomedecine Pharmacotherapie. 2022;150:112971.","journal-title":"Biomed Pharmacotherapy = Biomedecine Pharmacotherapie"},{"key":"7210_CR37","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12920-020-0692-3","volume":"13","author":"S Binder","year":"2020","unstructured":"Binder S, Zipfel I, Friedrich M, Riedel D, Ende S, K\u00e4mpf C, Wiedemann K, Buschmann T, Puppel S-H, Reiche K, et al. Master and servant: LINC00152 - a STAT3-induced long noncoding RNA regulates STAT3 in a positive feedback in human multiple myeloma. BMC Med Genom. 2020;13:22.","journal-title":"BMC Med Genom"},{"key":"7210_CR38","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.7150\/thno.81826","volume":"13","author":"H Feng","year":"2023","unstructured":"Feng H, Hu P, Chen Y, Sun H, Cai J, He X, Cao Q, Yin M, Zhang Y, Li Q, et al. Decreased miR-451a in cerebrospinal fluid, a marker for both cognitive impairment and depressive symptoms in alzheimer\u2019s disease. Theranostics. 2023;13:3021\u201340.","journal-title":"Theranostics"},{"key":"7210_CR39","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1007\/s40618-023-02115-2","volume":"46","author":"ZM Besharat","year":"2023","unstructured":"Besharat ZM, Trocchianesi S, Verrienti A, Ciampi R, Cantara S, Romei C, Sabato C, Noviello TMR, Po A, Citarella A, et al. Circulating miR-26b-5p and miR-451a as diagnostic biomarkers in medullary thyroid carcinoma patients. J Endocrinol Investig. 2023;46:2583\u201399.","journal-title":"J Endocrinol Investig"},{"key":"7210_CR40","doi-asserted-by":"publisher","first-page":"100412","DOI":"10.1016\/j.jbo.2022.100412","volume":"33","author":"D Cao","year":"2022","unstructured":"Cao D, Ge S, Li M. MiR-451a promotes cell growth, migration and EMT in osteosarcoma by regulating YTHDC1-mediated m6A methylation to activate the AKT\/mTOR signaling pathway. J Bone Oncol. 2022;33:100412.","journal-title":"J Bone Oncol"},{"key":"7210_CR41","doi-asserted-by":"publisher","first-page":"109962","DOI":"10.1016\/j.biopha.2020.109962","volume":"125","author":"L Tao","year":"2020","unstructured":"Tao L, Shu-Ling W, Jing-Bo H, Ying Z, Rong H, Xiang-Qun L, Wen-Jie C, Lin-Fu Z. MiR-451a attenuates doxorubicin resistance in lung cancer via suppressing epithelialmesenchymal transition (EMT) through targeting c-Myc. Biomed Pharmacotherapy = Biomedecine Pharmacotherapie. 2020;125:109962.","journal-title":"Biomed Pharmacotherapy = Biomedecine Pharmacotherapie"},{"key":"7210_CR42","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.cell.2018.01.011","volume":"172","author":"F Kopp","year":"2018","unstructured":"Kopp F, Mendell JT. Functional classification and experimental dissection of long noncoding RNAs. Cell. 2018;172:393\u2013407.","journal-title":"Cell"},{"key":"7210_CR43","doi-asserted-by":"crossref","unstructured":"Zhang S, Liu N, Cao P, Qin Q, Li J, Yang L, Xin Y, Jiang M, Zhang S, Yang J, Lu J. LncRNA BC200 promotes the development of EBV-associated nasopharyngeal carcinoma by competitively binding to miR-6834-5p to upregulate TYMS expression. Int J Biol Macromol. 2024:134837.","DOI":"10.1016\/j.ijbiomac.2024.134837"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07210-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-07210-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07210-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:55:27Z","timestamp":1762523727000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-07210-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,7]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7210"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-07210-x","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,7]]},"assertion":[{"value":"23 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study has been approved by the medical ethics committee of University of Electronic Science and Technology, Sichuan Province People\u2019s Hospital (Grant Number: 2018-49). Every MM patient included in this study were informed and signed consents.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"No potential conflict of interest was reported by the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"1243"}}